Royal Philips, a global leader in health technology, announced that it has acquired UF startup Xhale Assurance Inc, a US-based scale-up company developing and commercializing next-generation sensor technologies. Xhale Assurance’s unique, disposable pulse oximetry sensor is placed on the wing (ala) of the nose, and can reliably measure and transmit a patient’s heart rate and blood oxygenation under low perfusion (diminished blood circulation) conditions that are challenging for conventional fingertip pulse oximetry sensors.
Xhale is an alumni company of UF Innovate | Sid Martin Biotech. The company’s technology will broaden and differentiate Philips’ existing portfolio of oxygen saturation monitoring solutions and allow the company to expand into a currently underserved clinical segment. Financial details of the transaction were not disclosed.
“Xhale Assurance’s nasal alar sensor offers exceptional clinical capabilities and strengthens our patient monitoring offering with a next-generation pulse oximetry sensor technology,” said Felix Baader, Business Leader of Monitoring & Analytics at Philips. “The sensor technology also offers opportunities to develop measurements of further physiologic parameters. I am excited that this will augment our ability to offer solutions that enhance patient safety, support clinical workflow, improve caregiver efficiency, and help our customers implement value-based healthcare.”